Acumen appoints Schacterle as Chief Regulatory Officer, Head of Quality

Acumen Pharmaceuticals (ABOS) announced the appointment of Amy Schacterle, Ph.D., as Chief Regulatory Officer & Head of Quality, reporting to Jim Doherty, President & Chief Development Officer at Acumen. Most recently, Schacterle served as Senior Vice President of R&D Strategy and Business Management at Sage Therapeutics (SAGE)